Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e01996
Bikash Khadka , Kishor Khanal , Ashim Regmi , Anup Ghimire , Shirish KC , Rohini Nepal , on behalf of Doctors on Wheels
Pyopericardium is a rare cause of cardiac tamponade. We present a case of a dengue fever patient who presented with cellulitis of the upper limbs, later manifesting cardiac tamponade, which was fatal. Although echocardiography on admission revealed a small pericardial effusion only, it later manifested as tamponade, causing cardiogenic shock. Staphylococcus pyopericardium was found later. Early identification could be possible with bedside point-of-care ultrasonography and echocardiography. Emergent pericardiocentesis or pig tail drain placement is life saving.
{"title":"Pyopericardium progressing to cardiac tamponade in a patient with dengue fever","authors":"Bikash Khadka , Kishor Khanal , Ashim Regmi , Anup Ghimire , Shirish KC , Rohini Nepal , on behalf of Doctors on Wheels","doi":"10.1016/j.idcr.2024.e01996","DOIUrl":"https://doi.org/10.1016/j.idcr.2024.e01996","url":null,"abstract":"<div><p>Pyopericardium is a rare cause of cardiac tamponade. We present a case of a dengue fever patient who presented with cellulitis of the upper limbs, later manifesting cardiac tamponade, which was fatal. Although echocardiography on admission revealed a small pericardial effusion only, it later manifested as tamponade, causing cardiogenic shock. Staphylococcus pyopericardium was found later. Early identification could be possible with bedside point-of-care ultrasonography and echocardiography. Emergent pericardiocentesis or pig tail drain placement is life saving.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"36 ","pages":"Article e01996"},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000726/pdfft?md5=c0e260f49ca5e2ed20ea7f22cabe140c&pid=1-s2.0-S2214250924000726-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141242258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02013
Racha Ghoussaini , Omar Abu Saleh , Hussam Tabaja
Histoplasma vascular graft infection (VGI) is rarely reported, with only a handful of instances documented in the existing literature. Reporting Histoplasma VGI cases is important as they demonstrate previous treatment strategies and their outcomes. In this paper, we report a case of disseminated histoplasmosis with ascending aortic graft infection. Conservative therapy was attempted initially but failed, and our patient eventually required surgical graft explantation. Our case demonstrates the challenges in diagnosing and managing VGI caused by Histoplasma capsulatum.
{"title":"Graft versus histoplasma disease: A case of vascular graft infection","authors":"Racha Ghoussaini , Omar Abu Saleh , Hussam Tabaja","doi":"10.1016/j.idcr.2024.e02013","DOIUrl":"https://doi.org/10.1016/j.idcr.2024.e02013","url":null,"abstract":"<div><p><em>Histoplasma</em> vascular graft infection (VGI) is rarely reported, with only a handful of instances documented in the existing literature. Reporting <em>Histoplasma</em> VGI cases is important as they demonstrate previous treatment strategies and their outcomes. In this paper, we report a case of disseminated <em>histoplasmosis</em> with ascending aortic graft infection. Conservative therapy was attempted initially but failed, and our patient eventually required surgical graft explantation. Our case demonstrates the challenges in diagnosing and managing VGI caused by <em>Histoplasma capsulatum</em>.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e02013"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000891/pdfft?md5=3dc43cec3783c41c5775b83eb11e98f8&pid=1-s2.0-S2214250924000891-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141487669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02017
Leigh Cervino Ahern , Daniel Nixon , Patricia Pecora Fulco
Antiretroviral (ARV) absorption in persons living with human immunodeficiency virus (PLWH, HIV) with short bowel syndrome is limited. We describe a case of a 28-year-old male with newly diagnosed HIV and plasmablastic lymphoma with proximal jejunostomy necessitating parenteral nutrition. ARV therapy with dolutegravir 50 mg twice daily and once daily tenofovir/emtricitabine was initiated with documented malabsorption and delayed virologic suppression (VS). Dolutegravir dose titration with therapeutic drug monitoring (TDM) resulted in VS at month 12. ARV TDM with dose titration is an option for PLWH with malabsorptive states to maintain VS.
{"title":"Antiretroviral therapeutic drug monitoring in a patient with small bowel resection and new HIV diagnosis","authors":"Leigh Cervino Ahern , Daniel Nixon , Patricia Pecora Fulco","doi":"10.1016/j.idcr.2024.e02017","DOIUrl":"https://doi.org/10.1016/j.idcr.2024.e02017","url":null,"abstract":"<div><p>Antiretroviral (ARV) absorption in persons living with human immunodeficiency virus (PLWH, HIV) with short bowel syndrome is limited. We describe a case of a 28-year-old male with newly diagnosed HIV and plasmablastic lymphoma with proximal jejunostomy necessitating parenteral nutrition. ARV therapy with dolutegravir 50 mg twice daily and once daily tenofovir/emtricitabine was initiated with documented malabsorption and delayed virologic suppression (VS). Dolutegravir dose titration with therapeutic drug monitoring (TDM) resulted in VS at month 12. ARV TDM with dose titration is an option for PLWH with malabsorptive states to maintain VS.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e02017"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924000933/pdfft?md5=b70e807f77b2bc9af6b238b14be4df48&pid=1-s2.0-S2214250924000933-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141487725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02043
Javier A. Baena-Del Valle , Sergio D. Cruz-Romero , Martha L. Romero-Prieto , Adriana A. Flórez-Vargas , Diana M. Palacios-Ortiz , Guillermo E. Quintero-Vega , Mauricio A. Palau-Lázaro
Cytomegalovirus (CMV) can cause a broad range of diseases, with severity depending on immune status, comorbidities, and age. Initial CMV infection usually occurs in childhood and is typically asymptomatic, leading to lifelong latency. In immunocompromised patients, CMV can affect multiple organs, but salivary gland infections are rare. This study presents a case of a 66-year-old woman with B-cell acute lymphoblastic leukemia who developed swelling and pain in the right preauricular region during pre-transplant consolidation therapy. Despite a recent bone marrow biopsy indicating morphological remission and a flow cytometry analysis detecting only 0.04 % B lymphoblasts, she exhibited these symptoms. A CT scan revealed enlargement, hyperdensity, and enhancement of the right parotid glands, with accompanying subcutaneous edema. A biopsy of the right parotid gland showed a dense interstitial lymphoplasmacytic infiltrate with numerous Cowdry bodies and smaller granular cytoplasmic inclusions, all testing positive for CMV immunohistochemistry. The findings confirm the diagnosis of CMV sialadenitis in an immunocompromised patient. This case underscores the importance of considering CMV infections in similar clinical scenarios, particularly in patients with compromised immune systems.
巨细胞病毒(CMV)可导致多种疾病,其严重程度取决于免疫状态、合并症和年龄。初次感染 CMV 通常发生在儿童时期,通常没有症状,会导致终身潜伏。在免疫力低下的患者中,CMV 可影响多个器官,但唾液腺感染却很少见。本研究报告了一例 66 岁的 B 细胞急性淋巴细胞白血病女性患者,她在接受移植前巩固治疗期间出现右耳前区肿胀和疼痛。尽管最近的骨髓活检显示形态学缓解,流式细胞术分析也仅检测到 0.04% 的 B 淋巴细胞,但她还是出现了这些症状。CT 扫描显示右侧腮腺肿大、密度增高并增强,伴有皮下水肿。右腮腺活检显示间质密集的淋巴浆细胞浸润,伴有大量考德里小体和较小的颗粒状胞浆包涵体,免疫组化检测结果均为CMV阳性。这些结果证实了免疫功能低下患者患 CMV sialadenitis 的诊断。该病例强调了在类似临床情况下考虑 CMV 感染的重要性,尤其是在免疫系统受损的患者中。
{"title":"Medical Imagery: Cytomegalovirus sialadenitis in a patient with B-cell acute lymphoblastic leukemia","authors":"Javier A. Baena-Del Valle , Sergio D. Cruz-Romero , Martha L. Romero-Prieto , Adriana A. Flórez-Vargas , Diana M. Palacios-Ortiz , Guillermo E. Quintero-Vega , Mauricio A. Palau-Lázaro","doi":"10.1016/j.idcr.2024.e02043","DOIUrl":"10.1016/j.idcr.2024.e02043","url":null,"abstract":"<div><p>Cytomegalovirus (CMV) can cause a broad range of diseases, with severity depending on immune status, comorbidities, and age. Initial CMV infection usually occurs in childhood and is typically asymptomatic, leading to lifelong latency. In immunocompromised patients, CMV can affect multiple organs, but salivary gland infections are rare. This study presents a case of a 66-year-old woman with B-cell acute lymphoblastic leukemia who developed swelling and pain in the right preauricular region during pre-transplant consolidation therapy. Despite a recent bone marrow biopsy indicating morphological remission and a flow cytometry analysis detecting only 0.04 % B lymphoblasts, she exhibited these symptoms. A CT scan revealed enlargement, hyperdensity, and enhancement of the right parotid glands, with accompanying subcutaneous edema. A biopsy of the right parotid gland showed a dense interstitial lymphoplasmacytic infiltrate with numerous Cowdry bodies and smaller granular cytoplasmic inclusions, all testing positive for CMV immunohistochemistry. The findings confirm the diagnosis of CMV sialadenitis in an immunocompromised patient. This case underscores the importance of considering CMV infections in similar clinical scenarios, particularly in patients with compromised immune systems.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e02043"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924001197/pdfft?md5=e9a7c6dad47f33eba12e39c79101f6a2&pid=1-s2.0-S2214250924001197-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02051
Julia S. Turock , Colette J. Matysiak Match , Kristina Adachi , Karin Nielsen-Saines , Shangxin Yang , Sanchi Malhotra
Background
Mycobacterium cosmeticum is an emerging rapidly growing mycobacteria (RGM) species that has been rarely reported to cause human disease. RGM catheter-related bloodstream infections (CRBSI) are often challenging to treat given the need for line removal, variable species-dependent antimicrobial susceptibility, combination antimicrobial treatment, and historically longer courses of antibiotics.
Case presentation
We present a case of an immunocompetent pediatric patient with severe hemophilia B and M. cosmeticum CRBSI. While the patient’s hemophilia B precluded a standard line holiday, he successfully cleared his infection with two line exchanges followed by two weeks of antibiotics.
Conclusions
RGM, including emerging species M. cosmeticum, may be considered in patients with an indolent presentation of CRBSI. Our case suggests source control with shorter courses of antimicrobials can be successful.
背景美容分枝杆菌(Mycobacterium cosmeticum)是一种新出现的快速生长分枝杆菌(RGM),很少有报道称它会导致人类疾病。RGM导管相关血流感染(CRBSI)的治疗通常具有挑战性,因为需要拔除导管、对不同菌种的抗菌药敏感性不同、需要联合使用抗菌药治疗,而且抗生素的疗程历来较长。虽然该患者的血友病 B 使其无法进行标准的管路更换,但他通过两次管路更换和两周的抗生素治疗成功清除了感染。结论对于症状不明显的 CRBSI 患者,可以考虑使用 RGM,包括新出现的 cosmeticum。我们的病例表明,使用较短疗程的抗菌药物进行源头控制可以取得成功。
{"title":"Mycobacterium cosmeticum catheter-related bloodstream infection in an immunocompetent patient: A case report and review of the literature","authors":"Julia S. Turock , Colette J. Matysiak Match , Kristina Adachi , Karin Nielsen-Saines , Shangxin Yang , Sanchi Malhotra","doi":"10.1016/j.idcr.2024.e02051","DOIUrl":"10.1016/j.idcr.2024.e02051","url":null,"abstract":"<div><h3>Background</h3><p><em>Mycobacterium cosmeticum</em> is an emerging rapidly growing mycobacteria (RGM) species that has been rarely reported to cause human disease. RGM catheter-related bloodstream infections (CRBSI) are often challenging to treat given the need for line removal, variable species-dependent antimicrobial susceptibility, combination antimicrobial treatment, and historically longer courses of antibiotics.</p></div><div><h3>Case presentation</h3><p>We present a case of an immunocompetent pediatric patient with severe hemophilia B and <em>M. cosmeticum</em> CRBSI. While the patient’s hemophilia B precluded a standard line holiday, he successfully cleared his infection with two line exchanges followed by two weeks of antibiotics.</p></div><div><h3>Conclusions</h3><p>RGM, including emerging species <em>M. cosmeticum</em>, may be considered in patients with an indolent presentation of CRBSI. Our case suggests source control with shorter courses of antimicrobials can be successful.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e02051"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924001276/pdfft?md5=9b886bd4bcb567e6fbf91d8d92fd4bd7&pid=1-s2.0-S2214250924001276-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fitz-Hugh-Curtis (FHCS) is characterized by an inflammation of the hepatic capsule concomitant or following pelvic infection due to Chlamydia trachomatis or Neisseria gonorrhea. It is a rare condition occurring most often in a woman of childbearing age and very rare in male patients. Splenic involvement is also a rare form of abdominal tuberculosis. The association of these two conditions is very uncommon. We report the exceptional case of a 58- year-old HIV-positive male patient, with whom abdominal ultrasound helped diagnose FHCS associated with abdominal tuberculosis invovlving the spleen.
菲茨-休-柯蒂斯病(FHCS)的特点是在盆腔感染沙眼衣原体或淋病奈瑟菌的同时或之后出现肝囊炎症。这是一种罕见的疾病,多发于育龄妇女,男性患者非常罕见。脾脏受累也是腹腔结核的一种罕见形式。这两种疾病的关联非常罕见。我们报告了一例特殊病例,该病例是一名 58 岁的 HIV 阳性男性患者,腹部超声波检查帮助诊断出 FHCS 伴有侵犯脾脏的腹腔结核。
{"title":"Ultrasound findings of Fitz-Hugh-Curtis Syndrome (FHCS) associated with splenic tuberculosis in an HIV-positive male patient","authors":"Ibrahima Niang , Daouda Thioub , Mamadou Ly , Abdourahmane Ndong , Fallou Galass Niang , Abdoulaye Dione Diop , Sokhna Ba","doi":"10.1016/j.idcr.2024.e02036","DOIUrl":"10.1016/j.idcr.2024.e02036","url":null,"abstract":"<div><p>Fitz-Hugh-Curtis (FHCS) is characterized by an inflammation of the hepatic capsule concomitant or following pelvic infection due to <em>Chlamydia trachomatis</em> or <em>Neisseria gonorrhea</em>. It is a rare condition occurring most often in a woman of childbearing age and very rare in male patients. Splenic involvement is also a rare form of abdominal tuberculosis. The association of these two conditions is very uncommon. We report the exceptional case of a 58- year-old HIV-positive male patient, with whom abdominal ultrasound helped diagnose FHCS associated with abdominal tuberculosis invovlving the spleen.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e02036"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924001124/pdfft?md5=a4fb7863f78bfd6f08eb04bfa5b99aec&pid=1-s2.0-S2214250924001124-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02057
S. Jawad Zafar , Zachary Wynne , Thomas John , Lauren Groft Buzzalino , Akira A. Shishido , David J. Riedel
A 50-year-old woman living with untreated HIV and injection drug use presented with right shoulder pain. The shoulder exam and computed tomography (CT) scan were concerning for septic arthritis. She was started on empiric vancomycin and cefepime and underwent right shoulder debridement and humeral head resection. Bone cultures grew methicillin sensitive Staphylococcus aureus (MSSA); empiric broad-spectrum antibiotics were changed to cefazolin. The patient subsequently developed severe anemia refractory to blood transfusions approximately 6 days later. Further evaluation disclosed hemolytic anemia attributable to cefazolin. Antibiotic therapy was switched from cefazolin to daptomycin, and the patient was started on prednisone. She had sustained improvement in hemoglobin values above 6 g/dL without requiring further transfusions prior to hospital discharge. Drug-induced immune hemolytic anemia from cefazolin is rare but has been reported primarily in the perioperative setting. Here, we present a case following initiation of treatment for septic arthritis.
{"title":"Cefazolin-induced hemolytic anemia in septic arthritis: A case report","authors":"S. Jawad Zafar , Zachary Wynne , Thomas John , Lauren Groft Buzzalino , Akira A. Shishido , David J. Riedel","doi":"10.1016/j.idcr.2024.e02057","DOIUrl":"10.1016/j.idcr.2024.e02057","url":null,"abstract":"<div><p>A 50-year-old woman living with untreated HIV and injection drug use presented with right shoulder pain. The shoulder exam and computed tomography (CT) scan were concerning for septic arthritis. She was started on empiric vancomycin and cefepime and underwent right shoulder debridement and humeral head resection. Bone cultures grew methicillin sensitive <em>Staphylococcus aureus</em> (MSSA); empiric broad-spectrum antibiotics were changed to cefazolin. The patient subsequently developed severe anemia refractory to blood transfusions approximately 6 days later. Further evaluation disclosed hemolytic anemia attributable to cefazolin. Antibiotic therapy was switched from cefazolin to daptomycin, and the patient was started on prednisone. She had sustained improvement in hemoglobin values above 6 g/dL without requiring further transfusions prior to hospital discharge. Drug-induced immune hemolytic anemia from cefazolin is rare but has been reported primarily in the perioperative setting. Here, we present a case following initiation of treatment for septic arthritis.</p></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"37 ","pages":"Article e02057"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214250924001331/pdfft?md5=fc10850bc36aaf21a9b683eaecf81019&pid=1-s2.0-S2214250924001331-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141985033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02115
S. Belmahi , A. Saddari , H. Zrouri , Y. Sbibih , C. Ben moussa , O. Abdesselami , K. Ghomari , I. Alla , S. Kaddouri , A. Idrissi , S. Ezrari , E. Benaissa , Y. Ben Lahlou , M. Elouenass , A. Maleb
Introduction and importance
Providencia rettgeri, a member of the Morganellaceae family within the Enterobacterales order, is predominantly associated with urinary tract infections in hospitalized individuals, particularly those with indwelling urinary catheters. However, wound infections caused by P. rettgeri are exceedingly rare, with an estimated incidence of around 0.1 %. Here, we present a case of wound infection in a healthy child caused by P. rettgeri, highlighting the rarity of the organism and emphasizing the importance of prompte identification and appropriate antibiotic therapy.
Case report
A 4-year-old child presented with a soft tissue abscess in the left calf, following an injury sustained from a tree trunk a few days prior. The patient underwent wound debridement and abscess drainage, followed by empirical antibiotic therapy with amoxicillin and clavulanic acid. Bacteriological samples collected intraoperatively revealed colonies of P. rettgeri, identified with high certainty using the BD Phoenix™ 100 automated system. Antimicrobial susceptibility testing showed resistance to several antibiotics but sensitivity to third-generation cephalosporins, amikacin, and aztreonam. Antibiotic therapy was adjusted accordingly, leading to clinical improvement and discharge after ten days of hospitalization
Discussion
P. rettgeri, a Gram-negative bacillus, is a rare causative agent of wound infections. While predominantly associated with nosocomial urinary tract infections, it can rarely lead to various other infections, including wound infections, particularly in hospitalized or immunocompromised individuals. Resistance to multiple antibiotics, including carbapenems, poses challenges in treatment selection.
Conclusion
This case underscores the importance of considering P. rettgeri as a potential pathogen in wound infections, even in healthy individuals. Awareness of its presence and antibiotic susceptibility patterns is crucial for appropriate management and prevention of complications. Further studies are warranted to elucidate the epidemiology and clinical significance of P. rettgeri infections in different patient populations.
导言和重要性P. rettgeri 是肠杆菌科 Morganellaceae 家族的成员,主要与住院病人的尿路感染有关,尤其是使用留置导尿管的病人。然而,由 P. rettgeri 引起的伤口感染却极为罕见,估计发病率约为 0.1%。在此,我们介绍了一例由 P. rettgeri 引起的健康儿童伤口感染病例,突出了该病菌的罕见性,并强调了及时识别和适当抗生素治疗的重要性。病例报告一名 4 岁儿童因几天前被树干砸伤,导致左小腿软组织脓肿。患者接受了伤口清创和脓肿引流术,随后使用阿莫西林和克拉维酸进行了经验性抗生素治疗。术中采集的细菌样本显示有 P. rettgeri 菌落,使用 BD Phoenix™ 100 自动系统进行鉴定,结果非常确定。抗菌药物药敏试验显示,患者对多种抗生素产生耐药性,但对第三代头孢菌素、阿米卡星和唑特罗南敏感。讨论P. rettgeri 是一种革兰氏阴性杆菌,是一种罕见的伤口感染致病菌。虽然它主要与医院内尿路感染有关,但在极少数情况下也会导致其他各种感染,包括伤口感染,尤其是在住院或免疫力低下的人群中。对包括碳青霉烯类在内的多种抗生素的耐药性给治疗选择带来了挑战。结论本病例强调了将 P. rettgeri 视为伤口感染潜在病原体的重要性,即使是健康人也不例外。认识到它的存在和抗生素敏感性模式对于适当处理和预防并发症至关重要。有必要开展进一步研究,以阐明 P. rettgeri 在不同患者群体中的流行病学和临床意义。
{"title":"Wound infection with multidrug-resistant Providencia rettgeri: About a case report and littérature review","authors":"S. Belmahi , A. Saddari , H. Zrouri , Y. Sbibih , C. Ben moussa , O. Abdesselami , K. Ghomari , I. Alla , S. Kaddouri , A. Idrissi , S. Ezrari , E. Benaissa , Y. Ben Lahlou , M. Elouenass , A. Maleb","doi":"10.1016/j.idcr.2024.e02115","DOIUrl":"10.1016/j.idcr.2024.e02115","url":null,"abstract":"<div><h3>Introduction and importance</h3><div><em>Providencia rettgeri</em>, a member of the <em>Morganellaceae</em> family within the <em>Enterobacterales</em> order, is predominantly associated with urinary tract infections in hospitalized individuals, particularly those with indwelling urinary catheters. However, wound infections caused by <em>P. rettgeri</em> are exceedingly rare, with an estimated incidence of around 0.1 %. Here, we present a case of wound infection in a healthy child caused by <em>P. rettgeri</em>, highlighting the rarity of the organism and emphasizing the importance of prompte identification and appropriate antibiotic therapy.</div></div><div><h3>Case report</h3><div>A 4-year-old child presented with a soft tissue abscess in the left calf, following an injury sustained from a tree trunk a few days prior. The patient underwent wound debridement and abscess drainage, followed by empirical antibiotic therapy with amoxicillin and clavulanic acid. Bacteriological samples collected intraoperatively revealed colonies of <em>P. rettgeri,</em> identified with high certainty using the BD Phoenix™ 100 automated system. Antimicrobial susceptibility testing showed resistance to several antibiotics but sensitivity to third-generation cephalosporins, amikacin, and aztreonam. Antibiotic therapy was adjusted accordingly, leading to clinical improvement and discharge after ten days of hospitalization</div></div><div><h3>Discussion</h3><div><em>P. rettgeri</em>, a Gram-negative bacillus, is a rare causative agent of wound infections. While predominantly associated with nosocomial urinary tract infections, it can rarely lead to various other infections, including wound infections, particularly in hospitalized or immunocompromised individuals. Resistance to multiple antibiotics, including carbapenems, poses challenges in treatment selection.</div></div><div><h3>Conclusion</h3><div>This case underscores the importance of considering <em>P. rettgeri</em> as a potential pathogen in wound infections, even in healthy individuals. Awareness of its presence and antibiotic susceptibility patterns is crucial for appropriate management and prevention of complications. Further studies are warranted to elucidate the epidemiology and clinical significance of <em>P. rettgeri</em> infections in different patient populations.</div></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"38 ","pages":"Article e02115"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142700050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02105
A.R. Buonomo , L. Cattaneo , G. Viceconte , F. Calabria , G. Di Troia , A. Di Fusco , J. Mula , A. Cozzolino , L. Ametrano , A. D’Avolio , I. Gentile
Oritavancin is a novel long-acting lipoglycopeptide with in vitro activity against methicillin-resistant (MR) Gram-positive pathogens and a good bactericidal activity even in presence of biofilm forming bacteria. It has been approved for acute bacterial skin and skin structure infections (ABSSSI), but recent reports have demonstrated possible off-label uses, as for prosthetic joint infections (PJI), which, in more than half of cases, are caused by MR Gram positive organisms.
We reported a case of a man in his eighties with a late shoulder PJI caused by methicillin resistant Staphyloccus epidermidis (MRSE) with contraindications for surgical replacement and few oral therapeutic options for a long term suppressive antibiotic therapy. The prosthesis was retained, and the patient received ten outpatient sequential doses of 1200 mg of oritavancin for 28 weeks, based on therapeutic drug monitoring (TDM) as a guide for correct timing of administration of each dose. During oritavancin administration, the patient achieved clinical cure, with disappearance of the pain and regaining pre-infection joint mobility, with no side effects reported and no further surgery or hospitalization needed. The treatment is ongoing as a long-lasting suppressive antimicrobial therapy. Oritavancin could represent an excellent solution for treating PJI caused by MR organism, especially in patients who need a long-term suppressive therapy.
{"title":"Long-term oritavancin therapy for shoulder prosthetic joint infection: A case guided by therapeutic drug monitoring (TDM)","authors":"A.R. Buonomo , L. Cattaneo , G. Viceconte , F. Calabria , G. Di Troia , A. Di Fusco , J. Mula , A. Cozzolino , L. Ametrano , A. D’Avolio , I. Gentile","doi":"10.1016/j.idcr.2024.e02105","DOIUrl":"10.1016/j.idcr.2024.e02105","url":null,"abstract":"<div><div>Oritavancin is a novel long-acting lipoglycopeptide with in vitro activity against methicillin-resistant (MR) Gram-positive pathogens and a good bactericidal activity even in presence of biofilm forming bacteria. It has been approved for acute bacterial skin and skin structure infections (ABSSSI), but recent reports have demonstrated possible off-label uses, as for prosthetic joint infections (PJI), which, in more than half of cases, are caused by MR Gram positive organisms.</div><div>W<strong>e</strong> reported a case of a man in his eighties with a late shoulder PJI caused by methicillin resistant <em>Staphyloccus epidermidis</em> (MRSE) with contraindications for surgical replacement and few oral therapeutic options for a long term suppressive antibiotic therapy. The prosthesis was retained, and the patient received ten outpatient sequential doses of 1200 mg of oritavancin for 28 weeks, based on therapeutic drug monitoring (TDM) as a guide for correct timing of administration of each dose. During oritavancin administration, the patient achieved clinical cure, with disappearance of the pain and regaining pre-infection joint mobility, with no side effects reported and no further surgery or hospitalization needed. The treatment is ongoing as a long-lasting suppressive antimicrobial therapy. Oritavancin could represent an excellent solution for treating PJI caused by MR organism, especially in patients who need a long-term suppressive therapy.</div></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"38 ","pages":"Article e02105"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142652532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.1016/j.idcr.2024.e02117
Yuanwen Chen , Yisheng Zhou , Zhibin Xu
Background
Investigating the clinical characteristics and treatment strategies of pyogenic liver abscess (PLA) complicated by infective endocarditis (IE), this study draws on a successfully treated case of PLA caused by Klebsiella pneumoniae, alongside a literature review of similar cases.
Case Summary
We report a 50-year-old male with type 2 diabetes who presented with acute fever, chills, and a liver abscess. The patient was initially treated with intravenous ceftriaxone (2 g daily). Due to the onset of septic shock, the antibiotic regimen was escalated to piperacillin-tazobactam (4.5 g every 8 h) and levofloxacin (0.5 g daily). Ultrasound-guided percutaneous drainage of the liver abscess was performed, and blood cultures confirmed Klebsiella pneumoniae. Upon the development of infective endocarditis, the treatment was adjusted to a combination of ceftriaxone and amikacin for one week, followed by six weeks of ceftriaxone monotherapy, resulting in full recovery.
Conclusion
This case report illustrates the rare association of Klebsiella pneumoniae-induced PLA with IE in a diabetic patient. It emphasizes the importance of individualized treatment strategies, with insights drawn from this case contributing to the understanding of managing such complex infections. While the successful outcome of this case provides valuable clinical insights, it highlights the need for careful consideration in treatment approaches. The findings from this single case should guide clinicians in similar scenarios but should not be generalized without further evidence.
{"title":"Concurrent Klebsiella pneumoniae liver abscess and infective endocarditis: A rare case report and literature review","authors":"Yuanwen Chen , Yisheng Zhou , Zhibin Xu","doi":"10.1016/j.idcr.2024.e02117","DOIUrl":"10.1016/j.idcr.2024.e02117","url":null,"abstract":"<div><h3>Background</h3><div>Investigating the clinical characteristics and treatment strategies of pyogenic liver abscess (PLA) complicated by infective endocarditis (IE), this study draws on a successfully treated case of PLA caused by Klebsiella pneumoniae, alongside a literature review of similar cases.</div></div><div><h3>Case Summary</h3><div>We report a 50-year-old male with type 2 diabetes who presented with acute fever, chills, and a liver abscess. The patient was initially treated with intravenous ceftriaxone (2 g daily). Due to the onset of septic shock, the antibiotic regimen was escalated to piperacillin-tazobactam (4.5 g every 8 h) and levofloxacin (0.5 g daily). Ultrasound-guided percutaneous drainage of the liver abscess was performed, and blood cultures confirmed <em>Klebsiella pneumoniae</em>. Upon the development of infective endocarditis, the treatment was adjusted to a combination of ceftriaxone and amikacin for one week, followed by six weeks of ceftriaxone monotherapy, resulting in full recovery.</div></div><div><h3>Conclusion</h3><div>This case report illustrates the rare association of Klebsiella pneumoniae-induced PLA with IE in a diabetic patient. It emphasizes the importance of individualized treatment strategies, with insights drawn from this case contributing to the understanding of managing such complex infections. While the successful outcome of this case provides valuable clinical insights, it highlights the need for careful consideration in treatment approaches. The findings from this single case should guide clinicians in similar scenarios but should not be generalized without further evidence.</div></div>","PeriodicalId":47045,"journal":{"name":"IDCases","volume":"38 ","pages":"Article e02117"},"PeriodicalIF":1.1,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142700049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}